Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule.
A nonconditional mutant of B-tropic murine leukemia virus (MuLV), defective in polymerase, has been isolated by cloning chronically infected cells. The cell clone containing the mutant produced virus particles which were noninfectious. However, superinfection of the cells by replication-competent XC-negative viruses resulted in the rescue of virus capable of forming plaques in a modified XC test, termed the "complementation plaque assay" (A. Rein and R. H. Bassin, J. Virol. 28:656-660, 1978). Analysis of the noninfectious virions produced without superinfection demonstrated that they contained only 2 to 5% of the wild-type level of reverse transcriptase activity. Purification of this activity indicated that it was associated with a smaller molecule than that produced by wild-type virus. Cells producing the mutant virions did not contain the gag-pol precursor, Pr180gag-pol; however the cells contained proteins of 147K and 114K daltons precipitable with anti-pol serum. All of the normal structural proteins as well as 70S genomic RNA could be detected in the mutant particles. An interference test indicated that a functional ecotropic glycoprotein was synthesized by the mutant. These results indicate that the mutant has a unique defect in the pol gene.
D000818:Animals; D002460:Cell Line; D002999:Clone Cells; D003673:Defective Viruses / Q000235:genetics* / Q000254:growth & development; D004792:Enzyme Precursors / Q000235:genetics*; D005347:Fibroblasts; D051379:Mice; D008979:Moloney murine leukemia virus / Q000032:analysis / Q000235:genetics* / Q000254:growth & development; D009154:Mutation; D012367:RNA, Viral / Q000032:analysis; D012194:RNA-Directed DNA Polymerase / Q000235:genetics*; D014764:Viral Proteins / Q000032:analysis; D014779:Virus Replication
D004792:Enzyme Precursors; D012367:RNA, Viral; D014764:Viral Proteins; D012194:RNA-Directed DNA Polymerase